These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 29604543)
1. Design, synthesis and activity of BBI608 derivatives targeting on stem cells. Zhou Q; Peng C; Du F; Zhou L; Shi Y; Du Y; Liu D; Sun W; Zhang M; Chen G Eur J Med Chem; 2018 May; 151():39-50. PubMed ID: 29604543 [TBL] [Abstract][Full Text] [Related]
2. A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3). Li C; Chen C; An Q; Yang T; Sang Z; Yang Y; Ju Y; Tong A; Luo Y Eur J Med Chem; 2019 Jan; 162():543-554. PubMed ID: 30472602 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy. Feng KR; Wang F; Shi XW; Tan YX; Zhao JY; Zhang JW; Li QH; Lin GQ; Gao D; Tian P Eur J Med Chem; 2020 Sep; 201():112428. PubMed ID: 32603980 [TBL] [Abstract][Full Text] [Related]
4. Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Li Y; Rogoff HA; Keates S; Gao Y; Murikipudi S; Mikule K; Leggett D; Li W; Pardee AB; Li CJ Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1839-44. PubMed ID: 25605917 [TBL] [Abstract][Full Text] [Related]
5. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells. Li W; Zhang Q; Chen K; Sima Z; Liu J; Yu Q; Liu J BMC Complement Altern Med; 2019 Feb; 19(1):38. PubMed ID: 30709346 [TBL] [Abstract][Full Text] [Related]
6. Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor. Hubbard JM; Grothey A Drugs; 2017 Jul; 77(10):1091-1103. PubMed ID: 28573435 [TBL] [Abstract][Full Text] [Related]
7. BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC. MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP Cancer Lett; 2018 Aug; 428():117-126. PubMed ID: 29653268 [TBL] [Abstract][Full Text] [Related]
8. Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage. Bi S; Chen K; Feng L; Fu G; Yang Q; Deng M; Zhao H; Li Z; Yu L; Fang Z; Xu B Eur J Pharmacol; 2019 Jul; 855():252-261. PubMed ID: 31085238 [TBL] [Abstract][Full Text] [Related]
9. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells. Löcken H; Clamor C; Müller K J Nat Prod; 2018 Jul; 81(7):1636-1644. PubMed ID: 30003778 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting STAT3. Fan D; Liu P; Li Z; He X; Zhang L; Jiang W; Ang W; Yang T Bioorg Chem; 2024 Sep; 150():107565. PubMed ID: 38905884 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition. Li N; Ou J; Bao N; Chen C; Shi Z; Chen L; Sun J Bioorg Chem; 2020 Nov; 104():104208. PubMed ID: 32919131 [TBL] [Abstract][Full Text] [Related]
12. Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain. Qiu HY; Zhu X; Luo YL; Lin HY; Tang CY; Qi JL; Pang YJ; Yang RW; Lu GH; Wang XM; Yang YH Sci Rep; 2017 Jun; 7(1):2863. PubMed ID: 28588262 [TBL] [Abstract][Full Text] [Related]
13. The Use of Naphthoquinones and Furano-naphthoquinones as Antiinvasive Agents. Tsang NY; Chik WI; Sze LP; Wang MZ; Tsang SW; Zhang HJ Curr Med Chem; 2018; 25(38):5007-5056. PubMed ID: 28990521 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents. Xie R; Yao Y; Tang P; Chen G; Liu X; Yun F; Cheng C; Wu X; Yuan Q Eur J Med Chem; 2017 Jul; 134():1-12. PubMed ID: 28391133 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3. Wang X; He Q; Wu K; Guo T; Du X; Zhang H; Fang L; Zheng N; Zhang Q; Ye F Eur J Med Chem; 2019 Oct; 179():218-232. PubMed ID: 31254923 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Wu L; Liu Y; Li Y Molecules; 2018 Sep; 23(9):. PubMed ID: 30213123 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents. Wu LQ; Ma X; Liu ZP Bioorg Chem; 2021 Aug; 113():104995. PubMed ID: 34034133 [TBL] [Abstract][Full Text] [Related]
18. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells. Guha P; Gardell J; Darpolor J; Cunetta M; Lima M; Miller G; Espat NJ; Junghans RP; Katz SC Oncogene; 2019 Jan; 38(4):533-548. PubMed ID: 30158673 [TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones. Bhasin D; Etter JP; Chettiar SN; Mok M; Li PK Bioorg Med Chem Lett; 2013 Dec; 23(24):6864-7. PubMed ID: 24176397 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors. Xu K; Xiao Z; Tang YB; Huang L; Chen CH; Ohkoshi E; Lee KH Bioorg Med Chem Lett; 2012 Apr; 22(8):2772-4. PubMed ID: 22437113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]